# Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin

> **NCT01666665** · PHASE2,PHASE3 · TERMINATED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 36 (actual)

## Conditions studied

- Insulin Resistance
- Hypermetabolism
- Hyperglycemia

## Interventions

- **DRUG:** Metformin
- **DRUG:** Sugar pill

## Key facts

- **NCT ID:** NCT01666665
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2018-08
- **Final completion:** 2019-04-23
- **Target enrollment:** 36 (ACTUAL)
- **Why stopped:** At the request of the study site, this study has been closed and access to study-related data is unavailable. We are unable to submit the results-data.
- **Last updated:** 2019-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01666665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01666665, "Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01666665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*